ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
4.08
0.10 (2.51%)
At close: Oct 03, 2025, 3:59 PM
4.00
-1.96%
After-hours: Oct 03, 2025, 07:58 PM EDT
ADC Therapeutics S.A. Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 18.84M | 23.03M | 16.91M | 18.46M | 17.41M | 18.05M | 16.79M | 14.49M | 19.28M | 18.99M | 69.8M | 76.32M | 17.29M | 46.5M | 17.01M | 13.15M | 3.76M | n/a |
Cost of Revenue | 836K | 2.06M | 1.37M | 851K | 2.06M | 3.35M | 1.22M | 366K | 1.32M | 590K | 489K | 1.29M | 2.27M | 529K | 770K | 502K | 121K | 578K |
Gross Profit | 18M | 20.97M | 15.54M | 17.61M | 15.36M | 14.7M | 15.57M | 14.13M | 17.96M | 18.4M | 69.31M | 75.03M | 15.03M | 45.97M | 16.24M | 12.64M | 3.64M | -578K |
Operating Income | -44.15M | -28.46M | -32.44M | -35.56M | -29.04M | -33.61M | -39.98M | -37.4M | -39.79M | -51.57M | -10.74M | 6.87M | -69.41M | -40.36M | -62.78M | -57.79M | -70.48M | -70.67M |
Interest Income | 1.93M | 2.05M | 2.63M | 3.44M | 3.25M | 2.95M | 3.29M | 3.14M | 2.37M | 2.3M | 1.63M | 273K | 16K | 18.31M | 20K | 16K | 15K | 15K |
Pretax Income | -55.39M | -38.44M | -31.05M | -43.05M | -36.03M | -46M | -39.87M | -47.89M | -53.73M | -59.69M | -20.19M | -51.32M | -65.32M | -17.83M | -56.35M | -71.4M | -72.33M | -51.42M |
Net Income | -56.65M | -38.6M | -30.73M | -43.97M | -36.54M | -46.61M | -85.03M | -47.81M | -47.12M | -59.43M | -24.16M | -50.61M | -64.37M | -16.66M | -34.38M | -71.55M | -72.57M | -51.53M |
Selling & General & Admin | 18.97M | -598K | 20.87M | 20.68M | 20.94M | 23.42M | 25.22M | 23.09M | 26.46M | 30.49M | 31.31M | 36.46M | 35.9M | 37.38M | 36.53M | 33.63M | 34.59M | 31.49M |
Research & Development | 30.09M | 28.93M | 27.1M | 32.5M | 24.3M | 25.73M | 30.33M | 28.44M | 31.94M | 39.48M | 48.73M | 41.68M | 48.54M | 48.95M | 42.49M | 36.8M | 39.53M | 39.17M |
Other Expenses | 13.09M | 21.11M | n/a | n/a | 2.23M | 263K | n/a | n/a | 296K | n/a | n/a | n/a | 114K | 8K | n/a | n/a | n/a | n/a |
Operating Expenses | 62.15M | 49.44M | 47.98M | 53.18M | 44.4M | 48.31M | 55.55M | 51.53M | 57.75M | 69.97M | 80.05M | 78.14M | 84.44M | 86.33M | 79.02M | 70.44M | 74.12M | 70.67M |
Interest Expense | 13M | 12.23M | 11.92M | 13.12M | 12.68M | 12.5M | 7.67M | 12.94M | 10.31M | 10.42M | 9.8M | 11.36M | 8.8M | 9.22M | 9.52M | 4.26M | 2.56M | 2M |
Selling & Marketing Expenses | 4M | -10.55M | 5.72M | 5.06M | 4.85M | 5.81M | 13.93M | 8.04M | 8.33M | 15.35M | 16.18M | 8.24M | 17.66M | 18.37M | 18.6M | 17.05M | 15.22M | 13.91M |
Cost & Expenses | 62.99M | 51.5M | 49.35M | 54.03M | 46.45M | 51.67M | 56.77M | 51.9M | 59.07M | 70.56M | 80.54M | 79.44M | 86.7M | 86.86M | 79.79M | 70.94M | 74.24M | 70.67M |
Income Tax Expense | 1.25M | -165K | -321K | 90K | -86K | -84K | 43.17M | -86K | -6.61M | -262K | 3.97M | -711K | -947K | -1.17M | -21.97M | 145K | 240K | 107K |
Shares Outstanding (Basic) | 113.74M | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
Shares Outstanding (Diluted) | 113.74M | 107.2M | 105.4M | 104.82M | 95.69M | 82.55M | 82.29M | 82.26M | 81.47M | 80.81M | 80.64M | 78.37M | 76.91M | 76.82M | 76.4M | 76.74M | 76.73M | 76.72M |
EPS (Basic) | -0.5 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.74 | -0.3 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
EPS (Diluted) | -0.5 | -0.36 | -0.29 | -0.42 | -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.74 | -0.3 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 |
EBITDA | -41.55M | -28.46M | -18.83M | -29.7M | -22.52M | -32.66M | -26.96M | -32.99M | -37.12M | -47.35M | -8.3M | -37.38M | -54.13M | -5.52M | -43.31M | -64.27M | -69.14M | -48.31M |
EBIT | -42.4M | -26.49M | -19.63M | -30.5M | -23.35M | -33.51M | -26.96M | -33.79M | -42.34M | -48.05M | -12.64M | -39.96M | -56.52M | -6.11M | -46.83M | -64.93M | -69.77M | -48.89M |
Depreciation & Amortization | 840K | 801K | 793K | 802K | 838K | 843K | 1.01M | 793K | 769K | 694K | 802K | 572K | 586K | 594K | 759K | 658K | 635K | 578K |